SwanBio Therapeutics

📍 Bala Cynwyd, United States🗓 Founded 2018👥 8 employees💰 Last funded Nov 2020
Biotechnology Research🌐 spurtherapeutics.com
Website LinkedIn
SwanBio is now part of Spur Therapeutics. Our potential first-in-class gene therapy candidate for adrenomyeloneuropathy (AMN) has joined Spur’s expanding pipeline of next-generation genetic medicines. Learn more at spurtherapeutics.com.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
United Kingdom
1
Frequently asked questions
Who invested in SwanBio Therapeutics?
SwanBio Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did SwanBio Therapeutics last raise funding?
The most recent investment in SwanBio Therapeutics recorded on gritt.io was in November 2020.
When was SwanBio Therapeutics founded?
SwanBio Therapeutics was founded in 2018.
What industry is SwanBio Therapeutics in?
SwanBio Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is SwanBio Therapeutics based?
SwanBio Therapeutics is headquartered in Bala Cynwyd, United States.